The Q2 volume softness disclosure is the key negative signal — watch for Q2 earnings in August for magnitude of the miss and whether the IMPACT program can offset. The CEO transition from an internal COO with operational focus is neutral-to-slightly-positive for execution, but the volume headwind is the dominant near-term factor.
Price Chart
Executive Summary
Ardent Health appointed COO Dave Caspers as President and CEO, succeeding Marty Bonick who stepped down effective June 2, 2026. Caspers received a new employment agreement with a $900,000 base salary, 105% target bonus, and equity grants totaling $3M in grant-date fair value ($1.05M RSUs + $1.95M performance-based RSUs). The company reaffirmed full-year 2026 Adjusted EBITDA guidance of $485-$535M but disclosed Q2 volume softness, which is a negative signal that tempers the otherwise routine leadership transition.
Key Facts
- Dave Caspers appointed President and CEO effective June 2, 2026, succeeding Marty Bonick who stepped down
- Caspers' annual base salary set at $900,000 with target bonus of 105% of base salary for 2026
- One-time equity grants: $1,050,000 in time-based RSUs (3-year vesting) and $1,950,000 target in performance-based RSUs (2026 performance period, vesting April 2029)
- Full-year 2026 Adjusted EBITDA guidance reaffirmed at $485-$535 million
- CFO disclosed Q2 volume softness across portfolio, with IMPACT program accelerated and expanded in response
- Caspers has 24-month post-employment non-compete and non-solicitation covenants
- Severance: 2x salary + target bonus for non-CIC termination; 3x for termination within 6 months before to 18 months after Change in Control
Financial Impact
CEO transition with $3M in new equity grants; reaffirmed $485-$535M FY2026 Adjusted EBITDA guidance; Q2 volume softness noted
Risk Factors
- Q2 volume softness could lead to FY2026 guidance reduction if it persists into H2
- CEO transition execution risk despite internal appointment
- Potential for further operational disruption from accelerated IMPACT restructuring program
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-253567 |
| Document: d854796d8k.htm | 0001193125-26-253567 |
| Document: d854796dex991.htm | 0001193125-26-253567 |
| Document: 0001193125-26-253567-index-headers.html | 0001193125-26-253567 |
| Document: 0001193125-26-253567-index.html | 0001193125-26-253567 |
| Document: 0001193125-26-253567.txt | 0001193125-26-253567 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 3d ago | 8-K | $12.27 | awaiting T+20 | — | $12.18 (+0.73%) |
Aug 20, 2026 9w ago | 144 | $10.99 $10.61 | ▼ −3.46% | ▼ −2.93% | $12.18 (+10.83%) |
Aug 15, 2026 10w ago | Institutional Cluster | $10.89 $10.69 | ▼ −1.84% | ▲ +0.14% | $12.18 (+11.85%) |
Jun 30, 2026 16w ago | 8-K | $10.13 $10.93 | ▲ +7.90% | ▲ +10.08% | $12.18 (+20.24%) |
Jun 11, 2026 19w ago | Institutional Cluster | $9.67 $10.09 | ▲ +4.34% | ▲ +2.45% | $12.18 (+25.96%) |
Jun 2, 2026 20w ago | 8-K | $7.83 $10.76 | ▲ +37.42% | ▲ +38.42% | $12.18 (+55.56%) |
May 5, 2026 24w ago | 8-K | $9.37 $7.83 | ▼ −16.44% | ▼ −19.22% | $12.18 (+29.99%) |
Apr 8, 2026 28w ago | DEFA14A | $9.53 $9.37 | ▼ −1.68% | ▼ −9.25% | $12.18 (+27.81%) |
Mar 4, 2026 33w ago | 8-K | $9.44 $8.66 | ▼ −8.26% | ▼ −4.47% | $12.18 (+29.03%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers